Outcomes of SARS-CoV-2 Reinfection
// 17.6.2022
Corona in general
Impact of SARS-CoV-2 infection on menstrual cycle
Researchers systematically reviewed the impact of COVID-19 on the menstrual cycle. // 4.7.2022
The effects and mechanisms of SARS-CoV-2 on the nervous system
Researchers reviewed the neurologic manifestations associated with SARS-CoV-2. // 30.6.2022
First reported case of a person getting COVID from a cat
Nature - Scientists in Thailand have established that a tabby passed SARS-CoV-2 to a veterinary surgeon — although such cases of cat-to-human transmission are probably rare. // 29.6.2022
Scientists report autoimmunity from molecular mimicry between SARS-CoV-2 spike and human proteins
A new study focused on studying molecular mimicry between the S protein of SARS-CoV-2 and known epitopes, using a computational method. // 29.6.2022
Outcomes of SARS-CoV-2 Reinfection
First infection with SARS-CoV-2 is associated with increased risk of acute and post-acute death and sequelae in the pulmonary and extrapulmonary organ systems. However, whether reinfection adds to the risk incurred after the first infection is not clear. Here we use the national health care da... // 17.6.2022
SARS-CoV-2 damages cilia
Researchers determine whether the interaction between ORF10 and ZYG11B promotes the dissemination of SARS-CoV-2. // 15.6.2022
Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation
// 12.6.2022
COVID and smell loss: answers begin to emerge
Nature - Researchers are learning more about how the SARS-CoV-2 coronavirus stifles smell — and how they might revive it. // 9.6.2022
The association between vitamin D status and infections, hospitalization, and mortality due to COVID-19
Researchers explored the associations between vitamin D levels and SARS-CoV-2 infections, hospitalizations, and deaths in England. // 8.6.2022
Some people test positive for Covid-19 for weeks. Are they still infectious?
After contracting Covid-19, some people may continue to test positive on rapid tests for 10 days or longer—and experts are split about whether these individuals should continue to isolate past 10 days or just employ safety precautions until they test negative. // 1.6.2022
These 15 molecules trigger Covid smell disorder
Researchers identify compounds that trigger parosmia, the condition that makes coffee smell like burning rubbish // 1.6.2022
COVID death tolls: scientists acknowledge errors in WHO estimates
Nature - Researchers with the World Health Organization explain mistakes in high-profile mortality estimates for Germany and Sweden. // 1.6.2022
Global Covid-19 death toll ‘may be three times higher than official figures’
Researchers studying ‘excess deaths’ estimate that more than 18 million people died of disease by end of 2021 // 10.3.2022
COVID-19 Autopsies Reveal Underreporting of SARS-CoV-2 Infection and Scarcity of Co-infections
Coronavirus disease 2019 (COVID-19) mortality can be estimated based on reliable mortality data. Variable testing procedures and heterogeneous disease course suggest that a substantial number of COVID-19 deaths is undetected. // 14.4.2022
Clearing the Fog: A Systematic Review on Cognitive Dysfunction in COVID-19
Objective: The systematic review aims to examine the association between COVID-19 and cognitive dysfunction, including the link between the severity of COVID-19 and the occurrence of cognitive impairment and the potential pathophysiological mechanisms related to brain fog among COVID-19 patients. // 25.5.2022
Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses
// 24.5.2022
Morbidity and Mortality Weekly Report (MMWR) Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021
This report describes how survivors of COVID-19 were at higher risk for developing many other health conditions. // 24.5.2022
Omicron Infection Induces Low-Level, Narrow-Range SARS-CoV-2 Neutralizing Activity
Background The rapid worldwide spread of the mildly pathogenic SARS-CoV-2 Omicron variant has led to the suggestion that it will induce levels of collective imm… // 16.5.2022
”Interpretation Moderately symptomatic Omicron infection is only poorly immunogenic and does not represent a substitute for vaccination.”
Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study
// 13.5.2022
This is how many lives could have been saved with covid vaccinations in each state
// 13.5.2022
What Are the Recent Findings on COVID-19 Induced Inflammation?
A new study explores the role of monocytes in the pathogenesis of SARS-CoV-2. // 13.5.2022
Neuropsychiatric Risks of COVID: New Data
The risk of new-onset neuropsychiatric illness after severe COVID-19 is substantial but appears similar to other severe respiratory infections. // 11.5.2022
Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar
A number of studies reported that influenza vaccination is associated with lower risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and/or coronavirus disease 2019 (COVID-19) morbidity and mortality. We conducted a matched, test-negative, case-control study to estimate effectiveness of influenza vaccination, using Abbott’s quadrivalent Influvac Tetra vaccine, against SARS-CoV-2 infection and against severe COVID-19. // 10.5.2022
Most COVID Transmission Is Still Asymptomatic
Some 60% of spread starts with those who have no symptoms, and that may be higher with Omicron // 10.5.2022
Approximately 13% of hospitalized COVID patients have serious neurologic symptoms
In a recent study in the journal Critical Care Explorations, the Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry was used to record significant neurologic signs of SARS-CoV-2 infection, as well as prehospital risk factors and outcomes. // 9.5.2022
Exploring vitamin D and acute COVID-19 infection
Researchers assessed the presence of vitamin D deficiency in COVID-19-recovered patients // 6.5.2022
Potential indirect and direct effects of SARS-CoV-2 on pancreatic islets in patients who became hyperglycemic after COVID-19
In a recent study published in Diabetes, researchers assessed the direct and indirect effects of SARS-CoV-2 on human pancreatic islets. // 5.5.2022
Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model
Thus, despite the absence of virus in brain, neurons develop signatures of proteinopathies that may contribute to progressive neuronal dysfunction. // 16.4.2022
Long-term mortality following SARS-CoV-2 infection: A national cohort study from Estonia
People infected with SARS-COV-2 had more than three times the risk of dying over the following year compared with those who remained uninfected. // 28.4.2022